Arsena, Hermis, and Sri Melati Munir. “Efficacy and Safety of Adding Antiangiogenic Therapy to EGFR-Tyrosine Kinase Inhibitors Versus EGFR-Tyrosine Kinase Inhibitor Monotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials”. Bioscientia Medicina : Journal of Biomedicine and Translational Research 10, no. 7 (June 12, 2026): 2624-2636. Accessed June 16, 2026. https://www.bioscmed.com/index.php/bsm/article/view/1638.